Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000273628, also identified as AL354798.1, is classified as a pseudogene related to the ADP-ribose polymerase family, member 4 (PARP4)[1][3]. Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they are often the remnants of former genes that have lost their protein-coding or regulatory capacity through mutation. This entity does not produce a functional protein and has no known biological function, disease association, or role as a therapeutic target. Additional notes: - This entry is not a therapeutic target and should not be interpreted as a receptor, enzyme, transporter, or active member of any protein family. - There is an issue with the target: the name describes a pseudogene, which is not considered a druggable or functional target. - Relevant fields (biological function, disease role, targets of drugs, mechanism of action, safety, biomarker use) are null or not applicable for pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Info tpoly (ADP-ribose) polymerase family, member 4 pseudogene.